BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Policy

  Organogenesis Release: Nation’s Leading Developer Of Advanced Wound Care Technologies Urges FDA To Finalize Regulatory Guidance To Ensure Safety And Efficacy Of Section 361 HCT/Ps

  September 13, 2016

   · 

  5 min read
• Pharm Country

  Neo PLM Release: Pharmaceutical Manufacturing Poised For Massive Paradigm Shift Driven By Process PLM, New White Paper Contends

  September 13, 2016

   · 

  1 min read
• Business

  Horizon Discovery Ltd. Licenses Biomanufacturing Cell Lines To Centre For Process Innovation (CPI) And National Institute For Bioprocessing Research And Training (NIBRT)

  September 13, 2016

   · 

  2 min read
• Pharm Country

  Interpace Diagnostics Invited To Present Data At Upcoming American Thyroid Association Annual Meeting

  September 13, 2016

   · 

  5 min read
• Drug Development

  Adamas Pharma Announces Two Data Presentations On ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) At The 4th World Parkinson Congress

  September 13, 2016

   · 

  5 min read
• BioMidwest

  Centene Corporation To Present At BAML Global Healthcare Conference 2016 In London

  September 13, 2016

   · 

  1 min read
• Pharm Country

  Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference

  September 13, 2016

   · 

  1 min read
• Biotech Beach

  AmpliPhi Bio To Participate In Upcoming Conferences

  September 13, 2016

   · 

  1 min read
• Business

  Multiple Myeloma Research Foundation (MMRF) And Memorial Sloan-Kettering Cancer Center Collaborate On Minimal Residual Disease (MRD) Study In Multiple Myeloma

  September 13, 2016

   · 

  4 min read
• Drug Development

  Inotrem Successfully Completes Its First Phase I Clinical Trial With Motrem, A TREM-1 Pathway Modulator For The Treatment Of Septic Shock

  September 13, 2016

   · 

  1 min read